To further explore whether the effect of coptisine on diabetic nephropathy is associated with the activation of NLRP3 inflammasome, the level of NLRP3, an important component of the NLRP3 inflammasome, was detected by immunofluorescence as well as western blot after treatment with coptisine. The gene discussed is NLRP3; the disease is diabetic kidney disease.